Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Epigenetic-modification associated hnRNPA3 acts as a prognostic biomarker and promotes malignant progression of HCC

Fig. 1

HNRNPA3 Expression Analysis. A hnRNPA3 expression in cancer and normal tissues in pan-cancer TCGA dataset. B The relationship between hnRNPA3 and HCC clinicopathological features. C hnRNPA3 expression in HCC tumors and normal tissues from TCGA and GEO. D, E, F, G hnRNPA3 expression was correlated with worse prognosis of HCC (DFS, OS, PFS, RFS). H. The prognostic capacity of HNRNPA3 was evaluated by using the AUC at 1-,3- and 5-year of ROC curves

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us